☰

Jonathan K. Kish, Ph.D. - Publications

Affiliations: 
2012 Epidemiology (Medicine) University of Miami, Coral Gables, FL 
Area:
Epidemiology, Public Health, Oncology
Tree Info Similar researchers PubMed Report error

39 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Gajra A, Jeune-Smith Y, Kish J, Yeh TC, Hime S, Feinberg BA. Perceptions of community hematologists/oncologists on barriers to chimeric antigen receptor T-cell therapy for the treatment of diffuse large B-cell lymphoma. Immunotherapy. PMID 32552151 DOI: 10.2217/Imt-2020-0118  0.31
2020 Feinberg B, Kish J, Dokubo I, Wojtynek J, Gajra A, Lord K. Comparative Effectiveness of Palliative Chemotherapy in Metastatic Breast Cancer: A Real-World Evidence Analysis. Oncologist. 25: 319-326. PMID 31951300 DOI: 10.1634/Theoncologist.2019-0699  0.363
2020 Kish J, Miller T, Nero D, Liassou D, Liu X, McRoy L, Feinberg B, Zhan L, Trocio J. Abstract P5-14-13: Real-world dosing and CBC monitoring in patients with metastatic breast cancer during palbociclib plus letrozole therapy Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-P5-14-13  0.35
2019 Ryan KJ, Nero D, Feinberg BA, Lee CH, Pimentel R, Gajra A, Kish JK, Seal B. Real-world incidence and cost of pneumonitis post-chemoradiotherapy for stage III non-small-cell lung cancer. Future Oncology (London, England). PMID 31802700 DOI: 10.2217/Fon-2019-0524  0.311
2019 Abraham P, Kish JK, Korytowsky B, Radtchenko J, Singh P, Shaw J, Feinberg B. Real-world treatment patterns, cost of care and effectiveness of therapies for patients with squamous cell carcinoma of head and neck pre and post approval of immuno-oncology agents. Journal of Medical Economics. 1. PMID 31581922 DOI: 10.1080/13696998.2019.1676760  0.359
2019 Nabhan C, Kamat S, Kish JK. Acute myeloid leukemia in the elderly: what constitutes treatment value? Leukemia & Lymphoma. 60: 1164-1170. PMID 30407103 DOI: 10.1080/10428194.2018.1520992  0.312
2019 Feinberg BA, Lord K, Kish J, Laney JR, Chopra D, Liassou D. Real-world evidence evaluating the use of single versus combination chemotherapy in salvage therapy for metastatic breast cancer. Journal of Clinical Oncology. 37. DOI: 10.1200/Jco.2019.37.15_Suppl.E12600  0.314
2019 Lord K, Feinberg BA, Kish J, Laney JR, Chopra D, Liassou D. Real-world evidence evaluating the use of an NK-1 antiemetic in the systemic chemotherapy treatment of metastatic breast cancer. Journal of Clinical Oncology. 37. DOI: 10.1200/Jco.2019.37.15_Suppl.E12599  0.31
2019 Yu J, Kish JK, Paranagama D, Colucci P. Persistence of Ruxolitinib Treatment in Patients with Myelofibrosis at Community Oncology Practices in the United States-Contemporary Data Blood. 134: 5385-5385. DOI: 10.1182/Blood-2019-123833  0.324
2019 Mougalian S, Copher R, McAllister L, Radtchenko J, Wang E, Broscious M, Yu H, Kish J. Abstract P6-17-28: Outcomes of real-world use of eribulin plus trastuzumab for HER2-positive metastatic breast cancer Cancer Research. 79. DOI: 10.1158/1538-7445.Sabcs18-P6-17-28  0.344
2019 Feinberg BA, Kish J, Dokubo I, Wojtynek J, Lord K. Pcn325 Real-World Data Describing The Role Of Chemotherapy In The Treatment Of Hr+/Her2- Mbc Patients: Divergence From Evidence-Based Medicine Value in Health. 22. DOI: 10.1016/J.Jval.2019.09.520  0.326
2019 Kish J, Johnson C, Nabhan C, Sweat RS, Jeune-Smith Y, Feinberg BA. Pcn238 Cancer Patient Engagement In 2018 - Community Providers Perspectives On Digital Data And Communication At The Bedside Value in Health. 22. DOI: 10.1016/J.Jval.2019.04.359  0.336
2018 Kish JK, Ward MA, Garofalo D, Ahmed HV, McRoy L, Laney J, Zanotti G, Braverman J, Yu H, Feinberg BA. Real-world evidence analysis of palbociclib prescribing patterns for patients with advanced/metastatic breast cancer treated in community oncology practice in the USA one year post approval. Breast Cancer Research : Bcr. 20: 37. PMID 29720233 DOI: 10.1186/S13058-018-0958-2  0.375
2018 Nabhan C, Mato AR, Kish JK, Nero D. Comparison of Costs and Health Care Resource Utilization (HRU) in Chronic Lymphocytic Leukemia (CLL) Patients Treated with Venetoclax (VEN) or Chemotherapy (CT)/Chemoimmunotherapy (CIT) Blood. 132: 4758-4758. DOI: 10.1182/Blood-2018-99-118904  0.301
2018 Chung J, Merritt N, Kish J, Nabhan C, Feinberg BA. Pcn202 - Impact Of Comorbid Depression On Rates, Costs, And Health Care Resource Use In Breast Cancer Patients Value in Health. 21. DOI: 10.1016/J.Jval.2018.09.283  0.315
2018 Nabhan C, Smith Y, Klink A, Kish J, Feinberg B. Value-Based Care In Oncology: Challenges And Barriers Amongst Community Oncologists Value in Health. 21. DOI: 10.1016/J.Jval.2018.04.238  0.302
2017 Kish J, Feinberg BA, Maida T, Biggs C, Mujumdar U, Chopra D, Laney JR, Kennedy E. Opportunities for improving outcomes in pancreatic cancer patients: Characterizing the unresected “resectable” population. Journal of Clinical Oncology. 35: 274-274. DOI: 10.1200/Jco.2017.35.4_Suppl.274  0.32
2017 Kish J, Feinberg BA, Maida T, Biggs C, Mujumdar U, Chopra D, Laney JR, Kennedy E. Real-world evidence (RWE) to show improved time to progression among resected pancreatic cancer (RPC) patients receiving adjuvant chemotherapy (adjch). Journal of Clinical Oncology. 35: 242-242. DOI: 10.1200/Jco.2017.35.4_Suppl.242  0.335
2017 Nero D, Chung J, Mato AR, Kish J, Nabhan C. Comparative Study of Cardiovascular Co-Morbidities between Ibrutinib and Non-Ibrutinib-Treated Chronic Lymphocytic Leukemia (CLL) Patients Blood. 130: 4692-4692. DOI: 10.1182/Blood.V130.Suppl_1.4692.4692  0.327
2017 Kish J, Ward M, Garofalo D, Ahmed H, McRoy L, Laney J, Zanotti G, Yu H, Feinberg B. Abstract P6-16-05: Early utilization pattern of palbociclib 1 year post-approval in the United States Cancer Research. 77. DOI: 10.1158/1538-7445.Sabcs16-P6-16-05  0.382
2017 Kish J, Mougalian S, Copher R, McAllister L, Zhixiao W, Broscious M. Abstract P5-15-16: Utilization and outcomes of eribulin in triple negative metastatic breast cancer: Real-world findings Cancer Research. 77. DOI: 10.1158/1538-7445.Sabcs16-P5-15-16  0.396
2016 Seay JS, Mandigo M, Kish J, Menard J, Marsh S, Kobetz E. Intravaginal practices are associated with greater odds of high-risk HPV infection in Haitian women. Ethnicity & Health. 1-9. PMID 27774794 DOI: 10.1080/13557858.2016.1246423  0.524
2016 Bloudek L, Roy A, Kish JK, Siegel DS, Jagannath S, Globe D, Orloski L, Kuriakose ET. Estimating the Economic Impact of Adding Panobinostat to a U.S. Formulary for Relapsed and/or Refractory Multiple Myeloma: A Budget Impact and Cost-Benefit Model. Journal of Managed Care & Specialty Pharmacy. 22: 991-1002. PMID 27459662 DOI: 10.18553/Jmcp.2016.22.8.991  0.317
2016 Jagannath S, Roy A, Kish J, Lunacsek O, Globe D, Eaddy M, Kuriakose ET, Willey J, Butler-Bird S, Siegel D. Real-world Treatment Patterns and Associated Progression-Free Survival in Relapsed/Refractory Multiple Myeloma Among US Community Oncology Practices. Expert Review of Hematology. PMID 27291638 DOI: 10.1080/17474086.2016.1195254  0.332
2016 Feinberg BA, Kish JK, Garofalo D, Mujumdar U. Evaluation of real-world electronic medical record (EMR) treatment outcome data compared to clinical trial data for an advanced breast cancer treatment. Journal of Clinical Oncology. 34. DOI: 10.1200/Jco.2016.34.15_Suppl.E12506  0.372
2016 Kish J, Maida T, Feinberg B, Biggs C, Mujumdar U, Laney J, Chopra D, Kennedy G. Descriptive Analysis of the Resected Pancreatic Cancer Patient Journey: Findings from a U.S. Real-World Claims-Based Analysis Value in Health. 19. DOI: 10.1016/J.Jval.2016.09.2394  0.307
2016 Kish J, Maida T, Feinberg B, Biggs C, Mujumdar U, Chopra D, Laney J, Kennedy G. Patterns of Care Among Pancreatic Cancer Patients: Findings from a u.s. Real-world claims-based analysis Value in Health. 19. DOI: 10.1016/J.Jval.2016.09.2383  0.337
2016 Kish J, Feinberg B, Biggs C, Mujumdar U, Chopra D, Laney J, Kennedy G. Resource Utilization and Costs of Resected Pancreatic Cancer Patients Receiving Neoadjuvant Treatment: Findings from a Real-World U.S. Population Value in Health. 19. DOI: 10.1016/J.Jval.2016.09.2188  0.338
2016 Kish J, Feinberg B, Biggs C, Mujumdar U, Chopra D, Laney J, Kennedy G. Costs of Care Between Resected and Non-Resected Pancreatic Cancer Patients: Findings from a Real-World U.S. Population Value in Health. 19. DOI: 10.1016/J.Jval.2016.09.2153  0.323
2015 Shermock K, Seal BS, Asche CV, Chang J, Xia F, Kish JK, Zagadailov E, Eaddy M. Surgical, radiological, and chemotherapy treatment patterns for non-metastatic and metastatic gastric cancer. Journal of Clinical Oncology. 33: e15010-e15010. DOI: 10.1200/Jco.2015.33.15_Suppl.E15010  0.312
2015 Kish JK, Seal BS, Shermock K, Asche CV, Chang J, Xia F, Zagadailov E, Eaddy M. Adherence to guideline-recommended chemotherapy in the treatment of gastric cancer. Journal of Clinical Oncology. 33: e15009-e15009. DOI: 10.1200/Jco.2015.33.15_Suppl.E15009  0.302
2015 Seal BS, Shermock K, Asche CV, Chang J, Tangirala M, Kish JK, Zagadailov E, Eaddy M. Adherence to chemotherapy guidelines for non-metastatic (NM) and metastatic (M) colorectal cancer (CRC). Journal of Clinical Oncology. 33: e14690-e14690. DOI: 10.1200/Jco.2015.33.15_Suppl.E14690  0.353
2015 Jagannath S, Roy A, Kish JK, Lunacsek O, Eaddy MT, Kuriakose ET, Willey J, Siegel D. Progression-Free Survival in Third-Line Treatment of Relapsed/Refractory Multiple Myeloma Among Patients with Who Have Received Prior Bortezomib and Immunomodulatory Drugs Blood. 126: 3311-3311. DOI: 10.1182/Blood.V126.23.3311.3311  0.339
2015 Shermock K, Asche C, Seal B, Kreilick C, Chang J, Zagadailov E, Kish J, Eaddy M, Xia F. Cost of Care for Gastric Cancer In Patients With and Without Metastases Value in Health. 18: A201. DOI: 10.1016/J.Jval.2015.03.1165  0.308
2015 Seal B, Shermock K, Asche C, Kreilick C, Xia F, Kish J, Zagadailov E, Eaddy M. The Implications Of Using A 30-, 60-, Or 90-Day Gap In Treatment To Specify Lines Of Care In Gastric Cancer Treatment Value in Health. 18. DOI: 10.1016/J.Jval.2015.03.009  0.303
2014 Yao J, Kish JK, Stafkey-Mailey D, Eaddy M. Evaluation of national treatment trends in ovarian cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 204. PMID 28141421 DOI: 10.1200/Jco.2014.32.30_Suppl.204  0.324
2014 Smith LE, Bernal DR, Schwartz BS, Whitt CL, Christman ST, Donnelly S, Wheatley A, Guillaume C, Nicolas G, Kish J, Kobetz E. Coping with vicarious trauma in the aftermath of a natural disaster Journal of Multicultural Counseling and Development. 42: 2-12. DOI: 10.1002/J.2161-1912.2014.00040.X  0.513
2013 Kobetz E, Menard J, Kish J, Bishop I, Hazan G, Nicolas G. Impacts of the 2010 Haitian earthquake in the diaspora: findings from Little Haiti, Miami, FL. Journal of Immigrant and Minority Health / Center For Minority Public Health. 15: 442-7. PMID 22585312 DOI: 10.1007/S10903-012-9635-1  0.529
2012 Kobetz E, Kish JK, Campos NG, Koru-Sengul T, Bishop I, Lipshultz H, Barton B, Barbee L. Burden of Human Papillomavirus among Haitian Immigrants in Miami, Florida: Community-Based Participatory Research in Action. Journal of Oncology. 2012: 728397. PMID 22619675 DOI: 10.1155/2012/728397  0.523
Show low-probability matches.